220
Participants
Start Date
August 5, 2024
Primary Completion Date
December 31, 2029
Study Completion Date
June 30, 2030
Hydroxyurea
The study intervention will include initial treatment with low-dose hydroxyurea therapy at 10 mg/kg/day (range 7 - 15 mg/kg/day), with subsequent increase to moderate dose hydroxyurea therapy at 20 mg/kg/day (range 17.5 - 26 mg/kg/day) after at least two severe events requiring physician contact.
RECRUITING
Aminu Kano Teaching Hospital, Kano
RECRUITING
Murtala Muhammad Specialist Hospital, Kano
Aminu Kano Teaching Hospital
OTHER
Murtala Muhammed Specialist Hospital
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Vanderbilt University Medical Center
OTHER